Oxford Biomedica plc (LON:OXB)
London · Delayed Price · Currency is GBP · Price in GBX 790.00
-26.00 (-3.19%)
At close: Feb 12, 2026
Oxford Biomedica Market Cap
Oxford Biomedica has a market cap or net worth of 986 million as of February 12, 2026. Its market cap has increased by 125.36% in one year.
Market Cap
986.00M
Enterprise Value
1.04B
Revenue
151.21M
Ranking
n/a
PE Ratio
n/a
Stock Price
790.00
Market Cap Chart
Since September 22, 1997, Oxford Biomedica's market cap has increased from 17.39M to 986.00M, an increase of 5,568.71%. That is a compound annual growth rate of 15.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 986.00M | 32.58% |
| Dec 31, 2025 | 743.72M | 67.15% |
| Dec 31, 2024 | 444.94M | 108.92% |
| Dec 29, 2023 | 212.97M | -50.00% |
| Dec 30, 2022 | 425.96M | -59.79% |
| Dec 31, 2021 | 1.06B | 24.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genus | 2.09B |
| Oxford Nanopore Technologies | 1.40B |
| PureTech Health | 311.77M |
| Avacta Group | 260.26M |
| Scancell Holdings | 128.68M |
| Bioventix | 92.74M |
| 4basebio | 91.32M |
| Faron Pharmaceuticals Oy | 66.58M |